Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA “Material Time, Material Extent” Rule May Be Cloudy For Sunscreens

This article was originally published in The Tan Sheet

Executive Summary

Interim marketing for OTC drugs or "conditions" in the U.S. subject to a final or new monograph is barred under FDA's final rule on "material time, material extent" criteria
Advertisement

Related Content

FDA’s Rosebraugh Says OTC Labeling Studies Should Be More Rigorous
FDA’s Rosebraugh Says OTC Labeling Studies Should Be More Rigorous
FDA’s Rosebraugh Says OTC Labeling Studies Should Be More Rigorous
“Time & Extent” Botanical Candidates To Lead Off With Ginger, Valerian?
“Time & Extent” Botanical Candidates To Lead Off With Ginger, Valerian?
“Time & Extent” Botanical Candidates To Lead Off With Ginger, Valerian?
Sunscreen Monograph Effective Date Extended To Address UVA Standards
Non-Monograph Drugs Interim Marketing Preservation Urged By CHPA
Interim Marketing Of New Conditions Prohibited Under Proposed Rule
Interim Marketing Of New Conditions Prohibited Under Proposed Rule

Topics

Advertisement
UsernamePublicRestriction

Register

PS093542

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel